Novartis AG logo

Novartis AG

NVSEF | OTC
Chart Builder DCF Calculator
$138.10
-$0.28 (-0.20%)
Sep 24, 2026, 10:16 AM ET · Market open
TTM
Period Ending
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Q4 2020
Dec 30, 2020
Q3 2020
Sep 29, 2020
Q2 2020
Jun 29, 2020
Q1 2020
Mar 30, 2020
Revenue
55.19B 52.94B 50.78B 49B 47.92B 49.27B 51.01B 52.32B 53.07B 52.22B 51.83B 52.26B 52.79B 53B 52.88B 52.39B 51.56B 49.88B 49.9B 49.58B 49.53B 49.93B
Cost of Revenue
13.11B 13.02B 12.83B 12.53B 12.41B 13.51B 14.41B 15.46B 16.15B 15.56B 15.49B 15.39B 15.52B 15.68B 15.87B 16.11B 15.92B 15.44B 15.12B 14.9B 14.92B 14.9B
Gross Profit
42.08B 39.92B 37.95B 36.47B 35.51B 35.76B 36.6B 36.86B 36.92B 36.66B 36.34B 36.87B 37.27B 37.31B 37.01B 36.28B 35.63B 34.45B 34.78B 34.69B 34.61B 35.03B
Operating Income
16.68B 15.76B 14.63B 13.68B 11.81B 10.78B 10.12B 9.49B 9.89B 9.2B 9.2B 9.81B 10.88B 12.13B 11.69B 11.77B 10.95B 9.82B 10.15B 9.33B 9.28B 9.59B
Interest Income
317M 392M 398M 107M 88.25M 88.25M 186.25M 186.25M 179M 120M 36M 36M 36M 20M n/a n/a n/a n/a n/a n/a 12M 12M
Pretax Income
15.68B 15.01B 13.6B 12.69B 10.86B 9.76B 9.44B 8.8B 9.17B 8.44B 8.37B 23.58B 24.89B 26.36B 26.14B 11.75B 10.93B 9.71B 9.88B 9.08B 9.08B 9.42B
Net Income
13.71B 12.91B 11.94B 17.6B 16.18B 15.25B 14.85B 7.84B 7.65B 7.03B 6.96B 21.8B 22.98B 24.18B 24.02B 9.81B 8.98B 7.96B 8.07B 7.1B 7.21B 12.14B
Selling & General & Admin
13.14B 12.8B 12.5B 12.44B 12.4B 12.97B 13.66B 13.97B 14.29B 14.18B 14.25B 14.49B 14.7B 14.87B 14.89B 14.83B 14.63B 14.24B 14.2B 14.18B 14.31B 14.53B
Research & Development
10.33B 9.89B 9.69B 9.41B 10.94B 11.18B 11.81B 11.69B 10.5B 10.47B 10B 9.96B 9.61B 9.51B 9.54B 9.46B 9.23B 9.27B 8.98B 9.5B 9.55B 9.16B
Other Expenses
1.93B 1.45B 1.15B 785M n/a n/a n/a 35.45M 63.83M 136.51M 203.55M 170.13M 217.54M 241.38M 174.35M 172.33M 96.52M n/a n/a n/a n/a n/a
Operating Expenses
25.4B 24.14B 23.33B 22.8B 23.7B 24.97B 26.48B 27.37B 27.03B 27.46B 27.15B 27.06B 26.39B 25.19B 25.32B 24.51B 24.68B 24.62B 24.63B 25.36B 25.33B 25.45B
Interest Expense
1.11B 1.06B 1.01B 948M 906M 884M 863M 865M 849M 827M 828M 744M 740M 739M 740M 715M 722M 741M 778M 871M 878M 863M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
38.5B 37.17B 36.16B 35.32B 36.11B 38.49B 40.89B 42.84B 43.18B 43.02B 42.63B 42.45B 41.91B 40.87B 41.19B 40.61B 40.61B 40.06B 39.75B 40.25B 40.25B 40.34B
Income Tax Expense
1.98B 2.07B 1.69B 965.03M 804.03M 657.43M 676M 1.21B 1.52B 1.41B 1.42B 1.79B 1.91B 2.18B 2.12B 1.93B 1.94B 1.75B 1.81B 1.98B 1.87B 1.97B
Shares Outstanding (Basic)
1.95B 1.97B 1.99B 2.01B 2.03B 2.04B 2.05B 2.06B 2.08B 2.11B 2.14B 2.17B 2.2B 2.23B 2.24B 2.24B 2.24B 2.25B 2.27B 2.29B 2.29B 2.28B
Shares Outstanding (Diluted)
1.96B 1.98B 2B 2.03B 2.05B 2.06B 2.07B 2.08B 2.1B 2.12B 2.15B 2.18B 2.21B 2.24B 2.25B 2.25B 2.26B 2.27B 2.28B 2.3B 2.3B 2.29B
EPS (Basic)
6.90 6.44 5.88 8.82 8.06 7.57 7.40 3.76 3.67 3.32 3.22 9.79 10.29 10.81 10.72 4.35 3.97 3.50 3.55 3.13 3.18 5.30
EPS (Diluted)
6.86 6.40 5.85 8.77 8.02 7.53 7.35 3.73 3.63 3.29 3.19 9.72 10.22 10.73 10.65 4.33 3.95 3.48 3.52 3.09 3.14 5.24
EBITDA
22.71B 21.75B 20.47B 19.72B 18.99B 18.68B 18.73B 18.37B 17.56B 16.83B 16.51B 31.11B 31.62B 32.38B 32.45B 18.15B 17.92B 17.29B 17.21B 16.73B 16.41B 16.08B
EBIT
16.71B 15.97B 14.57B 13.77B 11.89B 10.7B 10.14B 9.43B 9.75B 9.12B 9.27B 24.39B 25.45B 26.6B 26.38B 11.99B 11.45B 10.54B 10.75B 9.95B 9.95B 10.28B
Depreciation & Amortization
6B 5.92B 6.04B 6.08B 7.12B 7.78B 8.52B 8.88B 7.86B 7.85B 7.24B 6.74B 6.19B 5.79B 6.08B 6.17B 6.47B 6.75B 6.46B 6.78B 6.45B 5.8B

© 2026 bestshares.com. All rights reserved.